# Current state
As of Sept 1, 2026, North Korea has tested missiles roughly monthly-to-bimonthly through 2026 (11th test of the year confirmed by Aug 12), with the most recent launch on Aug 20, 2026, tied to US-ROK drills. No moratorium or ceasefire is in place; September 2026 outcome is undetermined and will hinge on whether zero qualifying (ballistic/cruise/anti-ship) launches occur in the month.
# Timeline of key events
- 2026-01, 03 (x2), 04 (x3), 06: DPRK ballistic missile tests reported (confirmed, South Korean assessments) — steady 2026 cadence.
- Late June–Aug 5, 2026: ~6-week testing gap, first since late June (confirmed).
- 2026-08-06: DPRK fires short-range ballistic missile toward sea, days before US-ROK drills announced (confirmed, multiple outlets).
- 2026-08-12: DPRK fires 2nd ballistic missile in a week (11th of 2026), ahead of drills; some fell outside Japan EEZ (confirmed, Al Jazeera/Kyodo/TOI).
- 2026-08-19: Trump says he expects to meet Kim Jong Un "later this year" (confirmed statement, Washington Post).
- 2026-08-20: 3rd missile test that month, short-range ballistic missiles fired during US-ROK war games, days after Trump's meeting remarks (confirmed, antiwar.com/Al Jazeera).
- 2026-09-01: Seoul intelligence agency says US-NK summit "possible at any time," but Pyongyang's public response has been muted; analysts skeptical of imminent talks (reported, Euronews).
- Background: early June 2026, Kim Jong Un ordered 2.5x increase in ballistic/cruise missile production (confirmed); late Feb 2026, Kim ruled out talks, threatened South Korea (confirmed).
# Event
Will North Korea conduct fewer than 1 (i.e., zero) qualifying ballistic/cruise/anti-ship missile tests in September 2026?
# Outcomes to forecast
Yes (zero tests) / No (one or more tests)
# Kalshi market anchor
No direct Kalshi order book data returned; Polymarket sibling market (same ticker) shows current YES ("fewer than 1 test") price at **20%**, down sharply from a 7-day high (7d change: -18.5pp), but up 30d (+5.5pp). Range 14–38.5% over 12 days, $15.4K volume — thin but directionally bearish for "zero tests" recently.
# Sub-question answers
1. **Fraction of zero-test months (2021-26)** — Pooled 2019-24 base rate ~44% zero-months, but since-2022 "surge era" only ~19% (7/36 months) [code_execution]. Post-2022 rate is more relevant given current tempo.
2. **2025/2026 monthly cadence** — 2026: tests in Jan, Mar(x2), Apr(x3), Jun, then a ~6-week gap, then Aug 6/12/20 (11th test of year by Aug 12) [claude_news]. Cadence resumed and intensified in August, not decelerating.
3. **Active diplomacy/moratorium?** — No moratorium. Trump floated a Kim summit (Aug 19); Seoul intelligence says summit "possible at any time" (Sept 1), but DPRK response muted and analysts skeptical; Kim previously (Feb 2026) rejected talks and threatened South Korea [claude_news, Euronews].
4. **Seasonal triggers near Sept 2026** — US-ROK joint exercises (Ulchi Freedom Shield-style, referenced as ongoing Aug drills) and Sept 9 DPRK founding anniversary historically correlate with launches; code_execution model applies a 0.35-0.55 discount to zero-probability for September specifically.
5. **Polymarket price for zero tests** — 20% currently (down from recent highs of 38.5%), volume $15.4K, 12 data points [polymarket_direct].
6. **Related Kalshi/Polymarket signals** — No direct DPRK-specific sibling markets found on Kalshi (searches returned unrelated CFP/SCOTUS/S.Korea-president markets) [kalshi_related]; Polymarket search for other DPRK markets returned zero matches [polymarket_related]. No cross-market triangulation available.
# Key facts (high-confidence, factual)
1. [claude_news] DPRK conducted its 11th 2026 ballistic missile test by Aug 12; further tests Aug 20.
2. [claude_news] A ~6-week test gap occurred late June–early Aug 2026, showing testing is not perfectly continuous.
3. [claude_news] Kim ordered 2.5x increase in missile production capacity (June 2026); no moratorium announced.
4. [code_execution] Since 2022, ~81% of months had at least one DPRK missile test (19% zero-rate).
5. [polymarket_direct] Zero-test probability priced at 20%, having fallen from ~38.5% high.
# Cross-market signals
- Kalshi related: no DPRK-specific sibling markets found; irrelevant matches only.
- Polymarket: same-ticker price 20% YES (zero tests), declining trend over 7 days.
- Sportsbook implied: N/A.
# Analyst opinions and speculation
- [claude_news/thediplomat.com] Analysts note DPRK has "little incentive for dialogue" amid deepening confrontation; skepticism about imminent summit despite Trump's overtures.
- [code_execution model] Recommends central estimate P(zero tests, Sept 2026) ≈ 10–15%, i.e., 85-90% chance of at least one test, citing elevated 2022+ base rate and September-specific triggers (anniversary, joint drills).
# Directional lean per outcome
- **Yes (zero tests)**: Supported by June-Aug gap showing DPRK doesn't test every single month; some diplomatic overture noise (Trump-Kim summit talk) could theoretically induce restraint. Opposed by: resumed Aug tempo (3 tests in one month), production ramp-up, Sept 9 anniversary, no moratorium, skepticism of summit materializing quickly, historical low zero-rate since 2022 (~19%).
- **No (≥1 test)**: Strongly favored — recent monthly-repeated launches, provocation pattern tied to US-ROK drills/anniversaries, active weapons buildup, and base-rate model (85-90% probability of ≥1 test).
# Gaps / unknowns
- No confirmed schedule of Sept 2026 US-ROK exercises or exact Sept 9 anniversary program.
- No direct Kalshi YES price found for this specific ticker (only Polymarket data available) — treat Polymarket 20% as best available cross-market anchor.
- Whether Trump-Kim summit talks materialize in Sept 2026 (could suppress testing) remains unresolved/rumored only.
# Calibration anchors
- Polymarket YES (zero tests) price: 20% (declining from 38.5% high) — primary market anchor.
- Base-rate model central estimate: P(zero) ≈ 10-15% (code_execution), roughly consistent with Polymarket's 20% but slightly lower.
- Since-2022 historical zero-test month rate: ~19%.